Back to Search
Start Over
Quality assurance using quality indicators for prevention and early detection of cervical cancer in certified gynaecological dysplasia units and consultancies.
- Source :
-
Archives of gynecology and obstetrics [Arch Gynecol Obstet] 2024 Oct; Vol. 310 (4), pp. 2191-2202. Date of Electronic Publication: 2024 Aug 29. - Publication Year :
- 2024
-
Abstract
- Purpose: Cervical cancer is the fourth most common cancer in women worldwide. A successful screening concept for cervical cancer reduces the incidence and mortality of cervical cancer. Quality indicators (QIs) derived from the screening guidelines for cervical cancer and used by the certified dysplasia units and dysplasia consultancies are evaluated in this paper. The aim of this paper is to present the current data from the annual reports of these units and consultancies.<br />Methods: The results of the basic data and indicators for the audit year 2022 in the gynaecological dysplasia consultancies and units are presented. In 2022, 84 dysplasia consultancies and 42 units were audited. 40 units and 84 consultancies are included in the annual report. QI outcomes for patients treated in certified dysplasia units and dysplasia consultancies are analysed. Median, overall proportion, and standard deviation were calculated for each QI.<br />Results: The indicator year 2021 was analysed, which was audited in 2022 and evaluated in 2023. A total of nine QIs were analysed. Most target goals were met by the 84 certified dysplasia consultancies and by the 40 dysplasia units. The QIs evaluated are implemented to a very high degree. The targets for the three QIs were achieved by both the dysplasia consultancies and the units in at least 95% of the certified centres (QI 1: 100%, QI 2: 95%, QI 3: 100%; QI 1: 100%, QI 2: 97%, QI 3: 100%, respectively). The presentation of patients to the tumour board by the consultancies/units is working; the units are attending the tumour board more regularly than in previous years. Where the target was not met, the auditors issued deviations or reduced the duration of the certificate. The cases are discussed intensively in the sense of an individual case analysis and with the determination of measures on-site.<br />Conclusions: The targets for the various indicators were largely met by the dysplasia consultancies and units in the 2022 audit year. The certification of gynaecological dysplasia consultancies/units which have to cooperate with certified gynaecological cancer centres, has for the first time ensured the continuity of healthcare from prevention and early diagnosis to treatment of gynaecological cancers.<br /> (© 2024. The Author(s).)
- Subjects :
- Humans
Female
Uterine Cervical Dysplasia diagnosis
Uterine Cervical Dysplasia prevention & control
Referral and Consultation
Uterine Cervical Neoplasms diagnosis
Uterine Cervical Neoplasms prevention & control
Early Detection of Cancer standards
Quality Indicators, Health Care
Quality Assurance, Health Care
Subjects
Details
- Language :
- English
- ISSN :
- 1432-0711
- Volume :
- 310
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Archives of gynecology and obstetrics
- Publication Type :
- Academic Journal
- Accession number :
- 39207473
- Full Text :
- https://doi.org/10.1007/s00404-024-07694-w